Clinical trial
Prospective Observational Study Assessing the Prophylactic Effect of Topical Diclofenac on Hand-Foot Syndrome in Patients With Colorectal and Gastric Cancer Receiving Capecitabine
NCT07177560 is registered in ClinicalTrials.gov with Gazi University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study Assessing the Prophylactic Effect of Topical Diclofenac on Hand-Foot Syndrome in Patients With Colorectal and Gastric Cancer Receiving Capecitabine
- Lead sponsor
- Gazi University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 30, 2023
- Completion date
- February 28, 2024
- Enrollment
- 151 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
capecitabine, colorectal cancer, gastric cancer (gc), hand foot syndrome